In the literature, polymorphisms in TGFBR3 have been associated with inflammatory diseases other than SCD, such as Marfan syndrome, bladder cancer, and Behçet's disease [14, 16–18]. This evidence concerns the gene TGFBR3 and urinary bladder carcinoma.